Apo-Tek Lp(A)

FDA 510(k) K970302 · Perimmune, Inc.

Substantially Equivalent

510(k) numberK970302

Submission

Device name
Apo-Tek Lp(A)
Applicant
Perimmune, Inc.
Rockville, MD, US
Received
January 27, 1997
Decision date
November 10, 1997
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DFC – Lipoprotein, Low-Density, Antigen, Antiserum, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5600
Specialty
Immunology

Other 510(k)s with product code DFC

510(k)DeviceApplicantDecision
K253069Lipoprotein (a) Molarity AssayDFC · Traditional Diazyme Laboratories, Inc.06/16/2026SE
K241220Tina-quant Lipoprotein(a) Gen.2 MolarityDFC · Traditional Roche Diagnostics Operations01/24/2025SE
K211058Lp(a) UltraDFC · Traditional SENTINEL CH. SpA12/22/2022SE
K180074Diazyme Lipoprotein (a) AssayDFC · Traditional Diazyme Laboratories, Inc.03/22/2018SE
K123046Advia Chemistry Lipoprotein(A) Reagent Advia Chemistry Lipoprotein(A) CalibratorDFC · Traditional Siemens Healthcare Diagnostics, Inc.12/20/2012SE
K122722Cobas C Tina-Quant Lipoprotein (a) Gen 2 Assay Model 05852625190; Preciset LP (a) Gen 2…DFC · Traditional Roche Diagnostics11/29/2012SE
K082488Diazyme Lp(A) AssayDFC · Traditional General Atomics01/13/2009SE
K063838Lipoprotein(A), Lipoprotein(A) Calibrator, Lipoprotein (a) Control, Control HighDFC · Traditional Thermo Electron OY09/27/2007SE
K050487Quantia La(A)DFC · Traditional Biokit, S.A.04/26/2005SE
K023853K-Assay Lp(A) ControlsDFC · Traditional Kamiya Biomedical Co.12/13/2002SE

More from Kamiya Biomedical Co.

510(k)DeviceDecision
K970353Aura Tek FDPMMW · Traditional 04/30/1997SE

Questions and answers

When was Apo-Tek Lp(A) cleared by the FDA?

Apo-Tek Lp(A) (K970302) received a 510(k) decision of Substantially Equivalent on November 10, 1997, 287 days after the submission was received.

What is the product code of K970302?

The FDA product code is DFC – Lipoprotein, Low-Density, Antigen, Antiserum, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5600.